Arvinas Inc. (ARVN) and Pfizer (PFE) Announce PROTAC Protein Degrader ARV-471 Continues to Demonstrate Encouraging Clinical Benefit Rate in Patients with Locally Advanced or Metastatic ER+/HER2- Breas
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| (NASDAQ: ARVN) | Delayed: 7.64 +0.13 (1.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.51 | 52 Week High | $ | |||
| Open | $7.46 | 52 Week Low | $ | |||
| Day High | $7.74 | P/E | N/A | |||
| Day Low | $7.46 | EPS | $ | |||
| Volume | 560,049 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.28 +0.46 (1.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.82 | 52 Week High | $37.39 | |||
| Open | $27.61 | 52 Week Low | $28.25 | |||
| Day High | $28.29 | P/E | 17.14 | |||
| Day Low | $27.59 | EPS | $1.65 | |||
| Volume | 23,203,230 | |||||
